Abstract
Bisexual men are at increased risk for HIV compared to heterosexual men but unlikely to use pre-exposure prophylaxis (PrEP). Given that biases may influence whether bisexual men are prescribed PrEP, we examined whether medical students’ decision-making was influenced by the genders of a bisexual male patient’s partners. Medical students (N = 718) were randomized to one of nine conditions where they answered questions about a bisexual male patient after reviewing his electronic medical record. We manipulated the gender of his current partner (none, male, female) and the genders of his past partners (male, female, both). Current partners were described as living with HIV and not yet virally suppressed, past partners were described as being of unknown HIV-status, and condom use was described as intermittent with all partners. When the patient was not in a current relationship, perceived HIV risk and likelihood of prescribing PrEP were lowest if he only had female partners in the past. When he was in a current relationship, perceived HIV risk and likelihood of prescribing PrEP did not differ based on current or past partners’ genders. In addition, identification as a PrEP candidate, perceived likelihood of adherence, and perceived likelihood of engaging in condomless sex if prescribed were lower when the patient was not in a current relationship. Medical students appropriately prioritized the status of the partner living with HIV, but their decision-making was influenced by past partner genders when the patient was not in a current relationship. Medical students may require additional education to ensure they understand PrEP eligibility criteria and make decisions based on patients’ individual presentations.
Similar content being viewed by others
Availability of Data and Materials
Data are available from the lead author upon request.
Code Availability
Syntax for statistical analyses are available from the lead author upon request.
Notes
We re-ran our analyses including PrEP knowledge as a covariate and the pattern of significant findings remained the same.
References
Adams, L. M., & Balderson, B. H. (2016). HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report. AIDS Care, 28(9), 1154–1158. https://doi.org/10.1080/09540121.2016.1153595
American Association of Colleges of Osteopathic Medicine. (2022). 2021 facts: Enrollment, graduates, and MD-PhD data. https://www.aamc.org/data-reports/students-residents/interactive-data/2021-facts-enrollment-graduates-and-md-phd-data
Association of American Medical Colleges. (2022). AACOM reports on student enrollment. https://www.aacom.org/reports-programs-initiatives/aacom-reports/student-enrollment
Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet Infectious Diseases, 13(3), 214–222. https://doi.org/10.1016/S1473-3099(12)70315-8
Bates, L., Honeycutt, A., Bass, S., Green, T. A., & Farnham, P. G. (2021). Updated estimates of the number of men who have sex with men (MSM) with indications for HIV pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes, 88(4), e28–e30. https://doi.org/10.1097/QAI.0000000000002791
Bleasdale, J., Wilson, K., Aidoo-Frimpong, G., & Przybyla, S. (2020). Prescribing HIV pre-exposure prophylaxis: A qualitative analysis of health care provider training needs. Journal of HIV/AIDS and Social Services, 19(1), 107–123. https://doi.org/10.1080/15381501.2020.1712291
Blumenthal, J., & Haubrich, R. H. (2014). Will risk compensation accompany pre-exposure prophylaxis for HIV? AMA Journal of Ethics, 16(11), 909–915. https://doi.org/10.1001/virtualmentor.2014.16.11.stas1-1411
Brookmeyer, K. A., Coor, A., Kachur, R. E., Beltran, O., Reno, H. E., & Dittus, P. J. (2021). Sexual history taking in clinical settings: A narrative review. Sexually Transmitted Diseases, 48(6), 393–402. https://doi.org/10.1097/OLQ.0000000000001319
Bunting, S. R., Feinstein, B. A., Hazra, A., & Garber, S. S. (2021a). Effects of patient sexual orientation and gender identity on medical students’ decision making regarding preexposure prophylaxis for Human Immunodeficiency Virus prevention: A vignette-based study. Sexually Transmitted Diseases, 48(12), 959–966. https://doi.org/10.1097/OLQ.0000000000001488
Bunting, S. R., Feinstein, B. A., Hazra, A., Sheth, N. K., & Garber, S. S. (2021b). Knowledge of HIV and HIV pre-exposure prophylaxis among medical and pharmacy students: A national, multi-site, cross-sectional study. Preventive Medicine Reports, 24, 101590. https://doi.org/10.1016/j.pmedr.2021.101590
Bunting, S. R., Garber, S. S., Goldstein, R. H., Calabrese, S. K., Ritchie, T. D., & Batteston, T. J. (2020a). Health professions students’ awareness, knowledge, and confidence regarding pre-exposure prophylaxis (PrEP): Results of a national, multidisciplinary study. Sexually Transmitted Diseases, 48(1), 25–31.
Bunting, S. R., Garber, S. S., Goldstein, R. H., Ritchie, T. D., Batteson, T. J., & Keyes, T. J. (2020b). Student education about pre-exposure prophylaxis (PrEP) varies between regions of the United States. Journal of General Internal Medicine, 35(10), 2873–2881. https://doi.org/10.1007/s11606-020-05736-y
Caceres, B. A., Brody, A. A., Halkitis, P. N., Dorsen, C., Yu, G., & Chyun, D. A. (2018). Sexual orientation differences in modifiable risk factors for cardiovascular disease and cardiovascular disease diagnoses in men. LGBT Health, 5(5), 284–294. https://doi.org/10.1089/lgbt.2017.0220
Calabrese, S. K. (2020). Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation. Current HIV/AIDS Reports, 17(6), 579–588. https://doi.org/10.1007/s11904-020-00533-y
Calabrese, S. K., Earnshaw, V. A., Krakower, D. S., Underhill, K., Vincent, W., Magnus, M., Hansen, N. B., Kershaw, T. S., Mayer, K. H., Betancourt, J. R., & Dovidio, J. F. (2018). A closer look at racism and heterosexism in medical students’ clinical decision-making related to HIV pre-exposure prophylaxis (PrEP): Implications for PrEP education. AIDS and Behavior, 22(4), 1122–1138. https://doi.org/10.1007/s10461-017-1979-z
Calabrese, S. K., Earnshaw, V. A., Underhill, K., Hansen, N. B., & Dovidio, J. F. (2014). The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): Assumptions about sexual risk compensation and implications for access. AIDS and Behavior, 18(2), 226–240. https://doi.org/10.1007/s10461-013-0675-x
Calabrese, S. K., Tekeste, M., Mayer, K. H., Magnus, M., Krakower, D. S., Kershaw, T. S., Eldahan, A. I., Gaston Hawkins, L. A., Underhill, K., Hansen, N. B., Betancourt, J. R., & Dovidio, J. F. (2019). Considering stigma in the provision of HIV pre-exposure prophylaxis: Reflections from current prescribers. AIDS Patient Care and STDs, 33(2), 79–88. https://doi.org/10.1089/apc.2018.0166
CDC. (2018). Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: A clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf
CDC. (2021c). A guide to taking a sexual history. https://www.cdc.gov/std/treatment/SexualHistory.htm
CDC. (2021b). HIV Surveillance Report, 2019. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
CDC. (2021a). Preexposure prophylaxis for the prevention of HIV infection in the United States—2021a update: A clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021a.pdf
Dodge, B., Jeffries, W. L., & Sandfort, T. G. M. (2008). Beyond the down low: Sexual risk, protection, and disclosure among at-risk Black men who have sex with both men and women (MSMW). Archives of Sexual Behavior, 37(5), 683–696. https://doi.org/10.1007/s10508-008-9356-7
Dubov, A., Galbo, P., Altice, F. L., & Fraenkel, L. (2018). Stigma and shame experiences by MSM who take PrEP for HIV prevention: A qualitative study. American Journal of Men’s Health, 12(6), 1843–1854. https://doi.org/10.1177/1557988318797437
Feinstein, B. A., & Dodge, B. (2020). Meeting the sexual health needs of bisexual men in the age of biomedical HIV prevention: Gaps and priorities. Archives of Sexual Behavior, 49(1), 217–232. https://doi.org/10.1007/s10508-019-01468-1
Feinstein, B. A., Dodge, B., Korpak, A. K., Newcomb, M. E., & Mustanski, B. (2019a). Improving the health of cisgender men who identify as bisexual: What do they want from interventions? Sexuality Research and Social Policy, 16(3), 385–391. https://doi.org/10.1007/s13178-019-0380-2
Feinstein, B. A., & Dyar, C. (2017). Bisexuality, minority stress, and health. Current Sexual Health Reports, 9(1), 42–49. https://doi.org/10.1007/s11930-017-0096-3
Feinstein, B. A., Moran, K. O., Newcomb, M. E., & Mustanski, B. (2019b). Differences in HIV risk behaviors between self-identified gay and bisexual young men who are HIV-negative. Archives of Sexual Behavior, 48(1), 261–275. https://doi.org/10.1007/s10508-018-1148-0
Feinstein, B. A., Ford, J. V., Lattanner, M. R., Bo, N., Tu, W., & Dodge, B. (2021). The role of partner gender in bisexual men’s stigma-related experiences and mental health: Results from a probability-based sample in the United States. Stigma and Health. https://doi.org/10.1037/sah0000297
Felsher, M., Szep, Z., Krakower, D., Martinez-Donate, A., Tran, N., & Roth, A. M. (2018). “I don’t need PrEP right now”: A qualitative exploration of the barriers to PrEP care engagement through the application of the health belief model. AIDS Education and Prevention, 30(5), 369–381. https://doi.org/10.1521/aeap.2018.30.5.369
Finlayson, T., Cha, S., Xia, M., Trujillo, L., Denson, D., Prejean, J., Kanny, D., Wejnert, C., & the National HIV Behavioral Surveillance Study Group. (2019). Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. Morbidity and Mortality Weekly Report, 68(27), 597–603. https://doi.org/10.15585/mmwr.mm6827a1
Friedman, M. R., Dodge, B., Schick, V., Herbenick, D., Hubach, R. D., Bowling, J., Goncalves, G., Krier, S., & Reece, M. (2014a). From bias to bisexual health disparities: Attitudes toward bisexual men and women in the United States. LGBT Health, 1(4), 309–318. https://doi.org/10.1089/lgbt.2014.0005
Friedman, M. R., Stall, R., Silvestre, A. J., Mustanski, B., Shoptaw, S., Surkan, P. J., Rinaldo, C. R., & Plankey, M. W. (2014b). Stuck in the middle: Longitudinal HIV-related health disparities among men who have sex with men and women (MSMW). Journal of Acquired Immune Deficiency Syndromes, 66(2), 213–220. https://doi.org/10.1097/QAI.0000000000000143
Friedman, M. R., Wei, C., Klem, M. L., Silvestre, A. J., Markovic, N., & Stall, R. (2014c). HIV infection and sexual risk among men who have sex with men and women (MSMW): A systematic review and meta-analysis. PLoS ONE, 9(1), e87139. https://doi.org/10.1371/journal.pone.0087139
Furukawa, N. W., Maksut, J. L., Zlotorzynska, M., Sanchez, T. H., Smith, D. K., & Baral, S. D. (2020). Sexuality disclosure in U.S. gay, bisexual, and other men who have sex with men: Impact on healthcare-related stigmas and HIV pre-exposure prophylaxis denial. American Journal of Preventive Medicine, 59(2), e79–e87. https://doi.org/10.1016/j.amepre.2020.02.010
Grov, C., Rendina, H. J., Jimenez, R., & Parsons, J. T. (2016). Using online settings to idetnfiy gay and bisexual men willing to take or with experience taking PrEP: Implications for researchers and providers. AIDS Education and Prevention, 28(5), 378–392. https://doi.org/10.1521/aeap.2016.28.5.378
Jeffries, W. L. (2010). HIV testing among bisexual men in the United States. AIDS Education and Prevention, 22(4), 356–370. https://doi.org/10.1521/aeap.2010.22.4.356
Jin, F. Y., Prestage, G., Law, M. G., Kippax, S., Van de Ven, P., Rawsthorne, P., Kaldor, J. M., & Grulich, A. E. (2002). Predictors of recent HIV testing in homosexual men in Australia. HIV Medicine, 3(4), 271–276. https://doi.org/10.1046/j.1468-1293.2002.00121.x
Kamitani, E., Johnson, W. D., Wichser, M. E., Adegbite, A. H., Mullins, M. M., & Sipe, T. A. (2020). Growth in proportion and disparities of HIV PrEP use among key populations identified in the United States national goals: Systematic review and meta-analysis of published surveys. Journal of Acquired Immune Deficiency Syndromes, 84(4), 379–386. https://doi.org/10.1097/QAI.0000000000002345
Marcus, J. L., Hurley, L. B., Dentoni-Lasofsky, D., Ellis, C. G., Silverberg, M. J., Slome, S., Snowden, J. M., & Volk, J. E. (2019). Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California. AIDS Care, 31(5), 536–544. https://doi.org/10.1080/09540121.2018.1533238
Mayer, K. H., Agwu, A., & Malebranche, D. (2020a). Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Advances in Therapy, 37(5), 1778–1811. https://doi.org/10.1007/s12325-020-01295-0
Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., Wong, P., Ebrahimi, R., Zhong, L., Mathias, A., Callebaut, C., Collins, S. E., Das, M., McCallister, S., Brainard, D. M., & Hare, C. B. (2020b). Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): Primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Lancet, 396(10246), 239–254. https://doi.org/10.1016/S0140-6736(20)31065-5
Owens, D. K. (2019). Guideline: USPSTF recommends preexposure prophylaxis with antiretroviral therapy for persons at high risk for HIV. Annals of Internal Medicine, 171(8), JC38. https://doi.org/10.7326/ACPJ201910150-038
Pleuhs, B., Quinn, K. G., Walsh, J. L., Petroll, A. E., & John, S. A. (2020). Health care provider barriers to HIV pre-exposure prophylaxis in the United States: A systematic review. AIDS Patient Care and STDs, 34(3), 111–123. https://doi.org/10.1089/apc.2019.0189
Przybyla, S., Fillo, J., Kamper-DeMarco, K., Bleasdale, J., Parks, K., Klasko-Foster, L., & Morse, D. (2021). HIV pre-exposure prophylaxis (PrEP) knowledge, familiarity, and attitudes among United States healthcare professional students: A cross-sectional study. Preventive Medicine Reports, 22, 101334. https://doi.org/10.1016/j.pmedr.2021.101334
Przybyla, S. M., Parks, K., Bleasdale, J., Sawyer, J., & Morse, D. (2019). Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students. Currents in Pharmacy Teaching and Learning, 11(4), 352–360. https://doi.org/10.1016/j.cptl.2019.01.011
Rao, S., Reed, A. E., Parchem, B., Edelman, E. J., Magnus, M., Hansen, N. B., Kershaw, T. S., Earnshaw, V. A., Krakower, D. S., Dovidio, J. F., Mayer, K. H., Underhill, K., Rosenberger, J. G., Ogburn, D. F., Betancourt, J. R., & Calabrese, S. K. (2022). Optimizing provider preexposure prophylaxis (PrEP) training: A cross-sectional analysis of recommendations from providers across the PrEP implementation cascade. AIDS and Behavior, 26, 218–231. https://doi.org/10.1007/s10461-021-03375-w
Smith, D. K., Mendoza, M. C. B., Stryker, J. E., & Rose, C. E. (2016). PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS ONE, 11(6), e0156592. https://doi.org/10.1371/journal.pone.0156592
Sullivan, G. M., & Feinn, R. (2012). Using effect size—Or why the p value is not enough. Journal of Graduate Medical Education, 4(3), 279–282. https://doi.org/10.4300/JGME-D-12-00156.1
Thomann, M., Grosso, A., Zapata, R., & Chiasson, M. A. (2018). “WTF is PrEP?”: Attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Culture, Health and Sexuality, 20(7), 772–786. https://doi.org/10.1080/13691058.2017.1380230
Wood, B. R., McMahan, V. M., Naismith, K., Stockton, J. B., Delaney, L. A., & Stekler, J. D. (2018). Knowledge, practices, and barriers to HIV preexposure prophylaxis prescribing among Washington State medical providers. Sexually Transmitted Diseases, 45(7), 452–458. https://doi.org/10.1097/OLQ.0000000000000781
Funding
This project was supported by a grant from Gilead Sciences under award number [IN-US-412-9042]. The funder had no input on study design, implementation, data analysis, interpretation of results, drafting of the report, or the decision of where to submit the report for publication. Brian Feinstein’s time was supported by a grant from the National Institute on Drug Abuse [K08DA045575]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed Consent
Informed consent to participate was obtained from all participants.
Research Involving Human Participants and/or Animals
All study procedures were approved by the Institutional Review Board at Rosalind Franklin University of Medicine and Science prior to implementation. The study was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Feinstein, B.A., Chang, C.J., Bunting, S.R. et al. Willingness to Prescribe PrEP to Bisexual Men Depends on Genders of Their Past Partners: A Study of Medical Students in the USA. Arch Sex Behav 51, 2535–2547 (2022). https://doi.org/10.1007/s10508-022-02337-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-022-02337-0